课题基金 / 基金详情

Consequences of ubiquitin E2 enzyme (E2-25K) sumoylation

Consequences of ubiquitin E2 enzyme (E2-25K) sumoylation
泛素 E2 酶 (E2-25K) 苏酰化的后果
批准号:
197448029
负责人:
Privatdozentin Dr. Andrea Pichler, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2014-12-31

项目摘要

项目成果

Privatdozentin Dr. Andrea Pichler, Ph.D.的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Posttranslational modifications with ubiquitin and SUMO (small ubiquitin related modifier) are essential protein regulators involved in most cellular pathways. Ubiquitin and SUMO, themselves small proteins, are reversibly attached to their substrates depending on a tightly regulated enzymatic cascade. This involves the sequential action of a modifier specific E1 activating, E2 conjugating and E3 ligating enzyme for conjugation and specific enzymes for modifier specific deconjugation. Regulation is mainly performed at the level of E3 ligating and deconjugating enzymes, since these components ensure substrate specificity. Our work aims to gain insights into the consequences of E2 enzyme regulation which is expected to have widespread consequences on all downstream events, the cooperating E3 ligases and their substrates. In the proposed study we will investigate the biological consequences of regulating the ubiquitin conjugating enzyme E2-25K via sumoylation. Our recent biochemical findings indicated that upon sumoylation E2-25K switches its preference for E3 ligases. We now aim to study the consequences of E2-25K sumoylation in cell and mouse models by investigating the overall phenotype and also newly identified substrates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Upstream and downstream signals of Ubc9 sumoylation
国内基金
海外基金
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
  • 批准号:
    82371711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    吕志宝
  • 依托单位:
拟南芥转录因子MYB30的泛素化修饰和SUMO化修饰共同调节ABA信号转导的机理研究
  • 批准号:
    31400264
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2014
  • 负责人:
    郑远
  • 依托单位:
Ubiquitin B在逆转卵巢癌化疗耐药中的作用及机制研究
  • 批准号:
    81372806
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    吴鹏
  • 依托单位:
Nedd4-2/ClC-2泛素化信号通路在内侧颞叶癫痫发病机制中的作用
  • 批准号:
    81100846
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    吴丽文
  • 依托单位: